The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.

February 2026 saw a major biopharma acquisition, four key buyouts, and licensing deals in antibodies, small molecules, and ...

Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.

Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development ...

“Twenty years ago, or so, male infertility was not widely acknowledged or discussed. This reticence was driven by several factors – a lack of data highlighting prevalence of the problem, social stigma ...